Cathie Wood's position in Prime Medicine is currently worth $39.9 Million. That's 0.31% of their equity portfolio (52nd largest holding). The investor owns 5.09% of the outstanding Prime Medicine stock. The investor's estimated purchase price is $69.5 Million, resulting in a loss of 43%.